BioCentury
ARTICLE | Company News

Biovista, Pfizer deal

November 15, 2010 8:00 AM UTC

Biovista and Pfizer's Indications Discovery Unit will use Biovista's Clinical Outcome Search Space (COSS) technology to identify up to three new indications for undisclosed Pfizer drug candidates. The...